Country for PR: China
Contributor: PR Newswire Asia (China)
Monday, August 08 2022 - 14:59
AsiaNet
Xinhua Silk Road: E. China's Wuxi city steps up biomedical industry development
BEIJING, Aug. 8, 2022 /PRNewswire-AsiaNet/ --

The 2022 Taihu Bay Future Healthcare Conference held Thursday in Wuxi City in 
east China's Jiangsu Province witnessed the launch of Wuxi Intellectual 
Property Protection Center with 52 biomedical projects contracted, involving a 
total of more than 30 billion yuan investment.

Biomedical industry is an important part of Wuxi's modern industrial system 
construction during the 14th Five-Year Plan(2021-2025) period. Its scale topped 
140 billion yuan in 2021, a year-on-year increase of 24 percent, making Wuxi 
among the top 20 prefecture-level cities listed in China Biomedical Industry 
Barometer in 2021.

Besides the property protection center, six biomedical industrial parks were 
licensed and three biomedical public platforms were inaugurated at the 
conference, which are expected to inject impetus to the development of Wuxi's 
biomedical industry.

The city will strengthen and expand its industrial chain to build a 
200-billion-yuan modern biomedical industrial cluster, said Du Xiaogang, 
Secretary of the Wuxi Municipal Party Committee of CPC.

The biomedical industry started early in Wuxi. With good foundation, it has 
developed a relatively comp industry chain covering chemical raw medicine 
production, preparation production, and pharmaceutical service outsourcing, and 
gathered 1,278 biomedical companies such as AstraZeneca and WuXi Biologics 
AppTech, showing strong clustering effect. 

Aiming at building a world-class biomedical industry highland with distinctive 
characteristics, Wuxi not only issued a special policy tailored for the 
development of biomedical industrial parks, but also established a special fund 
for modern biomedical industry to reward breakthrough in the forward-looking 
technologies and innovation research. In 2021, Wuxi funded more than 32 million 
yuan for the science and technology development of 43 biomedical projects. 

Multiple fund agreements were signed at the conference, including a biomedical 
fund of 5 billion yuan jointly established by Guolian Group, AstraZeneca, and 
China International Capital Corporation Limited.

Original link: https://en.imsilkroad.com/p/329376.html

Source Xinhua Silk Road

Image Attachments Links:

   Link: https://iop.asianetnews.net/view-attachment?attach-id=427118

   Caption: Photo shows 2022 Taihu Bay Future Healthcare Conference site

Attachments
image1.png
Translations

Japanese